Management of Irregular Periods, Menorrhagia, and Offensive Vaginal Odor in a 34-Year-Old Woman with Elevated BMI
Your comprehensive diagnostic workup is appropriate, and the immediate priority is completing the STI screen, vaginal swabs, and hormonal evaluation before initiating treatment, while simultaneously addressing the menorrhagia with medical therapy and investigating for PCOS and structural causes. 1, 2
Immediate Management Priorities
Menorrhagia Treatment
- Initiate tranexamic acid 1300 mg three times daily during menstruation (days of bleeding only) as first-line therapy for heavy bleeding, which reduces menstrual blood loss by 34-59% over 2-3 cycles and is particularly effective when contraception is not immediately desired 2, 3
- Alternatively, consider mefenamic acid 500 mg three times daily for 5-7 days during bleeding episodes, which reduces both menstrual blood loss and pain 1, 4
- Start ferrous sulfate 200 mg three times daily immediately to correct anemia and replenish iron stores, continuing for three months after hemoglobin normalization 2
Infectious Workup
- Complete the planned STI screen (including chlamydia, gonorrhea, trichomonas) and vaginal swabs for bacterial vaginosis and candida immediately, as the offensive "rotten" odor strongly suggests BV or retained foreign body (though she reports using tampons currently) 1, 5
- The offensive odor with periods, described as "rotten," is highly suggestive of bacterial vaginosis, which commonly presents with malodorous discharge that worsens during menstruation 5
Diagnostic Evaluation for Irregular Periods
Hormonal Assessment
Your planned blood work is comprehensive and appropriate:
- FBC and coagulation studies are essential given the heavy bleeding with 3-5 tampon changes daily and constant morning blood, as up to 20% of women with heavy menstrual bleeding have an underlying inherited bleeding disorder 6, 7
- TSH, LH, FSH, total testosterone, prolactin, and 17-hydroxyprogesterone will evaluate for PCOS, thyroid dysfunction, and hyperprolactinemia—all common causes of irregular cycles 8, 4
- Given her hirsutism, weight gain of 20kg over 2 years, and BMI of 35.7, PCOS is highly likely, affecting 4-6% of women generally but presenting with exactly this constellation of symptoms 8
Imaging Requirements
- The planned pelvic ultrasound is mandatory given her BMI >35 and abnormal bleeding, as she meets criteria for structural evaluation 8, 2
- Transvaginal ultrasound is the first-line imaging modality for evaluating menorrhagia and can identify fibroids, polyps, and polycystic ovaries 2, 3
- Endometrial biopsy is not yet indicated at age 34 unless she has risk factors for endometrial cancer (such as prolonged unopposed estrogen from chronic anovulation), but should be performed if bleeding persists despite treatment 3, 9
PCOS-Specific Considerations
Diagnostic Criteria
- PCOS diagnosis requires irregular cycles, hyperandrogenism (clinical hirsutism or elevated testosterone), and/or polycystic ovaries on ultrasound (>10 peripheral cysts 2-8mm diameter) 8
- Her presentation of irregular periods, hirsutism (chin, neck, facial hair darkening), hair thinning, and significant weight gain strongly suggests PCOS 8
- Check fasting glucose and insulin levels with glucose/insulin ratio, as PCOS is associated with insulin resistance, and a ratio >4 suggests reduced insulin sensitivity 8
Cardiovascular Risk Assessment
- Women with PCOS require screening for cardiovascular disease risk factors, including monitoring weight every 6-12 months, at least annual blood pressure checks, fasting lipid panel, and glycemic control assessments 8
- Her BMI of 35.7 and 20kg weight gain over 2 years place her at increased metabolic risk 8
Long-Term Medical Management Options
Hormonal Therapy for Cycle Regulation
Once infection is ruled out and if pregnancy is not desired:
- The levonorgestrel-releasing intrauterine system (LNG-IUS) is the most effective medical treatment for menorrhagia, reducing menstrual blood loss by 96% after 12 months, and is particularly appropriate given her BMI and cardiovascular risk factors 2, 3
- Combined oral contraceptives (30-35 μg ethinyl estradiol with levonorgestrel or norgestimate) can regularize cycles, reduce bleeding, and are safe throughout reproductive years with no negative effect on long-term fertility 4, 2
- For PCOS specifically, combined hormonal contraceptives or cyclic progestins regulate menstrual cycles and reduce hyperandrogenic symptoms 8, 3
Non-Hormonal Alternatives
- NSAIDs (naproxen 440-550 mg every 12 hours or ibuprofen 600-800 mg every 6-8 hours with food) reduce menstrual blood loss by 20-60% 1, 9
- Tranexamic acid remains an excellent non-hormonal option for ongoing management 2, 7
Critical Follow-Up Plan
Timing and Monitoring
- Schedule pelvic examination after current menstruation ends to assess for structural abnormalities and complete the physical evaluation 1
- Re-evaluate at 3-6 months after initiating treatment to assess efficacy, monitoring hemoglobin and MCV every 3 months for 1 year, then annually 2
- Review all laboratory results and ultrasound findings at follow-up appointment to finalize diagnosis and adjust treatment accordingly 4, 2
Red Flags Requiring Urgent Reassessment
- If bleeding becomes uncontrolled with "flooding" (changing pad/tampon more frequently than hourly) or clots ≥1 inch diameter, this suggests more severe pathology or coagulopathy requiring urgent hematology referral 6
- Persistent offensive odor despite treatment for BV warrants consideration of retained foreign body or other structural pathology 5
- If endometrial biopsy shows hyperplasia with atypia, immediate referral to gynecologic oncologist is mandatory 3